The ABCB1/ABCG2 inhibitor elacridar is a more potent pharmacoenhancer compared to tariquidar for treatment of intracranial tumors with small molecule drugs
Van Tellingen, O., Lentzas, A., Zuidema, S., Çitirikkaya, C., Venekamp, N., Beijnen, J.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
P10.21.A THE ABCB1/ABCG2 INHIBITOR ELACRIDAR IS A MORE POTENT PHARMACOENHANCER COMPARED TO TARIQUIDAR FOR TREATMENT OF INTRACRANIAL TUMORS WITH SMALL MOLECULE DRUGS
Lentzas, A, de Gooijer, M C, Zuidema, S, Çitirikkaya, C H, Venekamp, N, Beijnen, J H, van Tellingen, O
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Get full text
Journal Article
P03.11.B MITOTIC ENRICHMENT AS AN EFFICIENT RADIOSENSITIZATION STRATEGY FOR INTRACRANIAL TUMORS
de Gooijer, M C, Çolakoğlu, H, Çitirikkaya, C H, Fedorushkova, D M, El Ouazani, A, Shah, R, Meel, M H, Hulleman, E, Borst, G R, van Tellingen, O
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Published in Neuro-oncology (Charlottesville, Va.) (08.09.2023)
Get full text
Journal Article
P04.91 ABC-drug efflux transporters at the blood-brain barrier limit the efficacy of treatment against primary and secondary brain tumors
van Tellingen, O, de Gooijer, M C, Buil, L C M, Fan, L, de Vries, N A, Kemper, E M, Citirikkaya, C, Beijnen, J H
Published in Neuro-oncology (Charlottesville, Va.) (19.09.2018)
Published in Neuro-oncology (Charlottesville, Va.) (19.09.2018)
Get full text
Journal Article